Global Non-Invasive Prenatal Testing Market is Estimated to Value Over USD 6 Billion by 2026 End

  • 19 Sep 2019

Global Non-Invasive Prenatal Testing Market is estimated to value over USD 6 billion by 2026 end and register a CAGR of over 12.8% during the forecast period 2019 to 2026.


Highly risky chromosomal abnormalities, improving reimbursement scenario for NIPT coupled with growing awareness regarding NIPT, and rising preference for non-invasive techniques are factors responsible for the non-invasive prenatal testing market growth. 

Nonetheless, societal and ethical restrictions and a lack of skilled professionals is restraining the non-invasive prenatal testing market growth. The Asia Pacific region is an untapped market space and has immense growth opportunities in the near future.


Trisomy Applications Segment is Anticipated to Dominate the Global Market Over the Forecast Period

Trisomy has the largest non-invasive prenatal testing market share in 2018 and it is predicted to grow significantly over the forecast period. Furthermore, this segment is estimated to grow at the highest CAGR over the forecast period. The high growth and large share of this segment can be primarily attributed to factors such as the rising incidence of chromosomal abnormalities and increasing maternal age. 

Regionally, the non-invasive prenatal testing market is bifurcated into North America, Europe, Asia, and the rest of the world. North America accounted for the largest non-invasive prenatal testing market share, followed by Europe. Additionally, the Asia Pacific is projected to proliferate at the highest CAGR over the forecast period. Rising conferences and awareness programs, increasing focus of prominent players on expanding their presence in Asia and the developing healthcare infrastructure are driving the non-invasive prenatal testing market growth in the region.


Key market players include Illumina Inc., Thermo Fisher Scientific Inc., GE Healthcare, Perkinelmer Inc., Agilent Technologies Inc., Beijing Genomics Institute, F. Hoffmann-La Roche Ltd., Laboratory Corp. of America Holdings, Natera Inc. and Yourgene Health.


Illumina Inc., one of the biggest names in this market, offers support services, NIPT, genotyping and whole-genome sequencing which further strengthen its market position. 


For the last three years, Illumina has launched multiple products to sustain its leading position in the non-invasive prenatal testing market. The company has invested a huge amount of its revenue on research and development expenditure. In 2018, Illumina invested over 18% of its revenue on research and development. Illumina expanded its non-invasive prenatal testing market size with the launch of VeriSeq NIPT Solution v2 in January 2019. 


The company also focuses on inert strategies with leading market players to strengthen its research & commercialization capabilities and develop advanced technologies. Illumina is projected to witness high non-invasive prenatal testing market growth over the forecast period, due to its strong product innovation capabilities, product portfolio, and wide regional presence.


Global Non-Invasive Prenatal Testing Market Segmentation:

By Product & Service

  • Products

a. Consumables

    • Assay Kits & Reagents
    • Disposables

b. Instruments

      • Ultrasound Devices
      • Next-Generation Sequencing Systems
      • Polymerase Chain Reaction Instruments
      • Microarrays
      • Other Instruments
    • Services


By Method

  • Ultrasound Detection
  • Biochemical Screening Tests
  • Cell-Free DNA in Maternal Plasma Tests


By Application

  • Trisomy
  • Microdeletion Syndrome
  • Other Applications


By End User

  • Diagnostic Laboratories
  • Hospitals


By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World


FutureWise Key Takeaways:

• Growth prospects

• SWOT analysis 

• Key trends 

• Key data-points affecting market growth 


Objectives of the Study:

  • To provide with an exhaustive analysis on the global non-invasive prenatal testing market by product & service, by method, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and rest of the world
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Get unlimited analyst support and customise this study further to your requirements, contact